BBIO
$67.25+0.51%
as of close, Oct 2, 2026
☾ AH $67.25 +0.51%
BridgeBio Pharma Inc.Stock · Health CareNasdaq Composite 0.03%US Stock Market 0.02%Russell 1000 0.02%Russell 3000 0.02%
BridgeBio Pharma Inc. monthly returns
BridgeBio Pharma Inc. has averaged 2.82% per month, positive in 51% of months. Month-by-month returns for BridgeBio Pharma Inc. (BBIO) below, through October 2, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.8%
82 months
Best month
+103.5%
Jul 2023
Worst month
-58.8%
Dec 2021
Positive months
51%
of all months
BridgeBio Pharma Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | +2.2% | |
| Sep 2026 | -14.1% | |
| Aug 2026 | -4.4% | |
| Jul 2026 | +7.5% | |
| Jun 2026 | +12.4% | |
| May 2026 | -6.8% | |
| Apr 2026 | -4.2% | |
| Mar 2026 | +11.7% | |
| Feb 2026 | -14.0% | |
| Jan 2026 | +1.0% | |
| Dec 2025 | +6.2% | |
| Nov 2025 | +15.0% | |
| Oct 2025 | +20.6% | |
| Sep 2025 | +0.3% | |
| Aug 2025 | +9.5% | |
| Jul 2025 | +9.5% | |
| Jun 2025 | +26.1% | |
| May 2025 | -10.7% | |
| Apr 2025 | +11.0% | |
| Mar 2025 | -0.9% | |
| Feb 2025 | +2.0% | |
| Jan 2025 | +24.7% | |
| Dec 2024 | +1.3% | |
| Nov 2024 | +15.7% | |
| Oct 2024 | -8.1% | |
| Sep 2024 | -8.6% | |
| Aug 2024 | +7.3% | |
| Jul 2024 | +2.4% | |
| Jun 2024 | -9.6% | |
| May 2024 | +9.3% | |
| Apr 2024 | -17.1% | |
| Mar 2024 | -9.5% | |
| Feb 2024 | -0.4% | |
| Jan 2024 | -15.1% | |
| Dec 2023 | +40.6% | |
| Nov 2023 | +10.3% | |
| Oct 2023 | -1.3% | |
| Sep 2023 | -11.8% | |
| Aug 2023 | -14.6% | |
| Jul 2023 | +103.5% | |
| Jun 2023 | +25.4% | |
| May 2023 | -5.5% | |
| Apr 2023 | -12.4% | |
| Mar 2023 | +45.2% | |
| Feb 2023 | +23.1% | |
| Jan 2023 | +21.8% | |
| Dec 2022 | -18.7% | |
| Nov 2022 | -10.2% | |
| Oct 2022 | +4.9% | |
| Sep 2022 | -5.3% | |
| Aug 2022 | +21.2% | |
| Jul 2022 | -4.6% | |
| Jun 2022 | +32.9% | |
| May 2022 | -14.8% | |
| Apr 2022 | -21.0% | |
| Mar 2022 | +30.1% | |
| Feb 2022 | -21.0% | |
| Jan 2022 | -40.8% | |
| Dec 2021 | -58.8% | |
| Nov 2021 | -18.0% | |
| Oct 2021 | +5.4% | |
| Sep 2021 | -6.5% | |
| Aug 2021 | -6.2% | |
| Jul 2021 | -12.3% | |
| Jun 2021 | +3.0% | |
| May 2021 | +5.9% | |
| Apr 2021 | -9.2% | |
| Mar 2021 | -12.8% | |
| Feb 2021 | +24.5% | |
| Jan 2021 | -20.2% | |
| Dec 2020 | +41.5% | |
| Nov 2020 | +30.9% | |
| Oct 2020 | +2.3% | |
| Sep 2020 | +25.7% | |
| Aug 2020 | +6.1% | |
| Jul 2020 | -13.7% | |
| Jun 2020 | +11.2% | |
| May 2020 | -3.9% | |
| Apr 2020 | +5.3% | |
| Mar 2020 | -9.0% | |
| Feb 2020 | -7.6% | |
| Jan 2020 | -1.6% | |
| Dec 2019 | +20.9% | |
| Nov 2019 | +28.3% | |
| Oct 2019 | +5.3% | |
| Sep 2019 | -29.6% | |
| Aug 2019 | +3.9% | |
| Jul 2019 | +8.8% |
Monthly total return (since Nov 2021)#
-100%-50%0%50%100%
Nov 2021-18%
Dec 2021-59%
Jan 2022-41%2022
Feb 2022-21%
Mar 2022+30%
Apr 2022-21%
May 2022-15%
Jun 2022+33%
Jul 2022-4.6%
Aug 2022+21%
Sep 2022-5.3%
Oct 2022+4.9%
Nov 2022-10%
Dec 2022-19%
Jan 2023+22%2023
Feb 2023+23%
Mar 2023+45%
Apr 2023-12%
May 2023-5.5%
Jun 2023+25%
Jul 2023+104%
Aug 2023-15%
Sep 2023-12%
Oct 2023-1.3%
Nov 2023+10%
Dec 2023+41%
Jan 2024-15%2024
Feb 2024-0.41%
Mar 2024-9.5%
Apr 2024-17%
May 2024+9.3%
Jun 2024-9.6%
Jul 2024+2.4%
Aug 2024+7.3%
Sep 2024-8.6%
Oct 2024-8.1%
Nov 2024+16%
Dec 2024+1.3%
Jan 2025+25%2025
Feb 2025+2.0%
Mar 2025-0.95%
Apr 2025+11%
May 2025-11%
Jun 2025+26%
Jul 2025+9.5%
Aug 2025+9.5%
Sep 2025+0.35%
Oct 2025+21%
Nov 2025+15%
Dec 2025+6.2%
Jan 2026+1.0%2026
Feb 2026-14%
Mar 2026+12%
Apr 2026-4.2%
May 2026-6.8%
Jun 2026+12%
Jul 2026+7.5%
Aug 2026-4.4%
Sep 2026-14%
Oct 2026+2.2%
Methodology#
Monthly returns are total returns (dividends reinvested), computed from BBIO's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is BridgeBio Pharma Inc.'s average monthly return?
- BridgeBio Pharma Inc. (BBIO) has averaged about 2.82% per month, positive in roughly 51% of months. The best month was Jul 2023 (+103.5%) and the worst was Dec 2021 (-58.8%).
More on BridgeBio Pharma Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100